Test
L33 Therapeutics of T2DM
Este test tiene tipos de pregunta que se abren en el reproductor de siempre.
Preguntas del test (3)
1- Pre-diabetes:
HbA1c [blank_start]41-49[blank_end] mmol/mol
Patients should be advised on diet and lifestyle modification. If >[blank_start]35[blank_end] do CVR assessment. Measure HbA1c [blank_start]yearly[blank_end].
- Diabetes:
HbA1c ≥ [blank_start]50[blank_end] mmol/mol
Full diabetes management- A41-49
- B50
- C35
- Dyearly
2An HbA1c measurement of > 86 mmol/mol indicates severe diabetes.
- AVerdadero
- BFalso
3Treatment steps:
1. [blank_start]Metformin[blank_end] is first line ([blank_start]Acarbose[blank_end]* if patient can’t take metformin or sulphonylureas)
2. Add a [blank_start]sulphonylurea or a DPP-4 inhibitor[blank_end]
3. [blank_start]Pioglitazone[blank_end] in addition to, or instead of, metformin ± sulphonylurea
4. Add [blank_start]insulin[blank_end], usually once or twice daily.
and, IF hypertensive (likely);
5. An ACE inhibitor, or an [blank_start]angiotensin II receptor blocker[blank_end] (ARB) if not tolerated
*Low effect, GI tarcet ADRs- AMetformin
- BAcarbose
- Csulphonylurea or a DPP-4 inhibitor
- DPioglitazone (PPAR-gamma activator)
- Einsulin
- Fangiotensin II receptor blocker
Información
- Descripción
- El usuario ha eliminado su información de asignaturas Test sobre L33 Therapeutics of T2DM, creado por Usuario eliminado el 16/04/2019.
- Autor
- Usuario eliminado
- Idioma
- English
- Visitas
- 35
- Historial
- Creado el 16 abr 2019 · actualizado el 26 may 2019
- Etiquetas
- Valoración
- Aún sin valoraciones Valora este test